JP2003508534A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003508534A5 JP2003508534A5 JP2001522227A JP2001522227A JP2003508534A5 JP 2003508534 A5 JP2003508534 A5 JP 2003508534A5 JP 2001522227 A JP2001522227 A JP 2001522227A JP 2001522227 A JP2001522227 A JP 2001522227A JP 2003508534 A5 JP2003508534 A5 JP 2003508534A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- hal
- independent
- groups
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 125000002947 alkylene group Chemical group 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- -1 COOA Chemical group 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19942474A DE19942474A1 (de) | 1999-09-06 | 1999-09-06 | Pyrazolo[4,3-d]pyrimidine |
| DE19942474.8 | 1999-09-06 | ||
| PCT/EP2000/008257 WO2001018004A2 (de) | 1999-09-06 | 2000-08-24 | PYRAZOLO[4,3-d]PYRIMIDINE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003508534A JP2003508534A (ja) | 2003-03-04 |
| JP2003508534A5 true JP2003508534A5 (enExample) | 2011-07-14 |
| JP4975921B2 JP4975921B2 (ja) | 2012-07-11 |
Family
ID=7920966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001522227A Expired - Fee Related JP4975921B2 (ja) | 1999-09-06 | 2000-08-24 | ピラゾロ［４，３−ｄ］ピリミジン |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6777419B1 (enExample) |
| EP (1) | EP1210349B1 (enExample) |
| JP (1) | JP4975921B2 (enExample) |
| KR (1) | KR20020025253A (enExample) |
| CN (1) | CN1145627C (enExample) |
| AR (1) | AR025569A1 (enExample) |
| AT (1) | ATE231866T1 (enExample) |
| AU (1) | AU773878B2 (enExample) |
| BR (1) | BR0013781A (enExample) |
| CA (1) | CA2384037C (enExample) |
| CZ (1) | CZ294587B6 (enExample) |
| DE (2) | DE19942474A1 (enExample) |
| DK (1) | DK1210349T3 (enExample) |
| ES (1) | ES2189766T3 (enExample) |
| HU (1) | HUP0202624A3 (enExample) |
| MX (1) | MXPA02002383A (enExample) |
| NO (1) | NO20021083D0 (enExample) |
| PL (1) | PL353366A1 (enExample) |
| PT (1) | PT1210349E (enExample) |
| RU (1) | RU2249594C2 (enExample) |
| SK (1) | SK3132002A3 (enExample) |
| WO (1) | WO2001018004A2 (enExample) |
| ZA (1) | ZA200202653B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10031584A1 (de) | 2000-06-29 | 2002-01-10 | Merck Patent Gmbh | 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine |
| DE10058662A1 (de) * | 2000-11-25 | 2002-05-29 | Merck Patent Gmbh | Verwendung von Pyrazolo[4,3-d]pyrimidinen |
| PL362513A1 (en) * | 2000-12-19 | 2004-11-02 | Merck Patent Gmbh | Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| DE10103647A1 (de) * | 2001-01-27 | 2002-08-01 | Merck Patent Gmbh | Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates |
| DE10148883A1 (de) * | 2001-10-04 | 2003-04-10 | Merck Patent Gmbh | Pyrimidinderivate |
| EP1620437B1 (en) | 2003-04-29 | 2009-06-17 | Pfizer Limited | 5,7-diaminopyrazolo¬4,3-d pyrimidines useful in the traetment of hypertension |
| US7572799B2 (en) * | 2003-11-24 | 2009-08-11 | Pfizer Inc | Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| GB0327323D0 (en) * | 2003-11-24 | 2003-12-31 | Pfizer Ltd | Novel pharmaceuticals |
| ATE417849T1 (de) * | 2004-04-07 | 2009-01-15 | Pfizer | Pyrazoloä4,3-düpyrimidine |
| EP1881985B1 (en) | 2005-05-12 | 2010-12-29 | Pfizer, Inc. | Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide |
| NL2000291C2 (nl) | 2005-11-10 | 2009-02-17 | Pfizer Prod Inc | 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan. |
| CA2831634C (en) * | 2011-04-21 | 2019-11-12 | Origenis Gmbh | Pyrazolo [4,3-d] pyrimidines useful as kinase inhibitors |
| CZ308056B6 (cs) * | 2015-07-20 | 2019-11-27 | Ustav Experimentalni Botaniky Av Cr V V I | 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky |
| US10034861B2 (en) | 2016-07-04 | 2018-07-31 | H. Lundbeck A/S | 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors |
| AR113926A1 (es) | 2017-12-14 | 2020-07-01 | H Lundbeck As | Derivados de 1h-pirazolo[4,3-b]piridinas |
| RU2020118913A (ru) | 2017-12-14 | 2022-01-14 | Х. Лундбекк А/С (H. Lundbeck A/S) | Виды комбинированного лечения, предусматривающего введение 1h-пиразолo[4,3-b]пиридинов |
| US11535611B2 (en) | 2017-12-20 | 2022-12-27 | H. Lundbeck A/S | Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors |
| US10766893B2 (en) * | 2017-12-20 | 2020-09-08 | H. Lundbeck A/S | 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256650A (en) * | 1989-03-29 | 1993-10-26 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
| GB9114760D0 (en) * | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
| DE19644228A1 (de) * | 1996-10-24 | 1998-04-30 | Merck Patent Gmbh | Thienopyrimidine |
| AU730670B2 (en) * | 1997-04-25 | 2001-03-08 | Pfizer Limited | Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction |
| DE19752952A1 (de) * | 1997-11-28 | 1999-06-02 | Merck Patent Gmbh | Thienopyrimidine |
| DE10031584A1 (de) * | 2000-06-29 | 2002-01-10 | Merck Patent Gmbh | 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine |
| DE10058662A1 (de) * | 2000-11-25 | 2002-05-29 | Merck Patent Gmbh | Verwendung von Pyrazolo[4,3-d]pyrimidinen |
| DE10060388A1 (de) * | 2000-12-05 | 2002-06-06 | Merck Patent Gmbh | Verwendung von Pyrazolo [4,3-d]pyrimidinen |
| DE10103647A1 (de) * | 2001-01-27 | 2002-08-01 | Merck Patent Gmbh | Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates |
-
1999
- 1999-09-06 DE DE19942474A patent/DE19942474A1/de not_active Withdrawn
-
2000
- 2000-08-24 DE DE50001191T patent/DE50001191D1/de not_active Expired - Lifetime
- 2000-08-24 AU AU72793/00A patent/AU773878B2/en not_active Ceased
- 2000-08-24 DK DK00960511T patent/DK1210349T3/da active
- 2000-08-24 EP EP00960511A patent/EP1210349B1/de not_active Expired - Lifetime
- 2000-08-24 KR KR1020027002893A patent/KR20020025253A/ko not_active Ceased
- 2000-08-24 ES ES00960511T patent/ES2189766T3/es not_active Expired - Lifetime
- 2000-08-24 CN CNB008137366A patent/CN1145627C/zh not_active Expired - Fee Related
- 2000-08-24 PT PT00960511T patent/PT1210349E/pt unknown
- 2000-08-24 WO PCT/EP2000/008257 patent/WO2001018004A2/de not_active Ceased
- 2000-08-24 RU RU2002107453/04A patent/RU2249594C2/ru not_active IP Right Cessation
- 2000-08-24 MX MXPA02002383A patent/MXPA02002383A/es active IP Right Grant
- 2000-08-24 CZ CZ2002736A patent/CZ294587B6/cs not_active IP Right Cessation
- 2000-08-24 HU HU0202624A patent/HUP0202624A3/hu unknown
- 2000-08-24 CA CA002384037A patent/CA2384037C/en not_active Expired - Fee Related
- 2000-08-24 JP JP2001522227A patent/JP4975921B2/ja not_active Expired - Fee Related
- 2000-08-24 BR BR0013781-2A patent/BR0013781A/pt not_active IP Right Cessation
- 2000-08-24 SK SK313-2002A patent/SK3132002A3/sk unknown
- 2000-08-24 US US10/070,305 patent/US6777419B1/en not_active Expired - Fee Related
- 2000-08-24 AT AT00960511T patent/ATE231866T1/de not_active IP Right Cessation
- 2000-08-24 PL PL00353366A patent/PL353366A1/xx unknown
- 2000-09-06 AR ARP000104648A patent/AR025569A1/es unknown
-
2002
- 2002-03-05 NO NO20021083A patent/NO20021083D0/no not_active Application Discontinuation
- 2002-04-04 ZA ZA200202653A patent/ZA200202653B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003508534A5 (enExample) | ||
| JP2003531118A5 (enExample) | ||
| JP2007510619A5 (enExample) | ||
| JP2002513026A5 (enExample) | ||
| JP2002501057A5 (enExample) | ||
| JP2002541233A5 (enExample) | ||
| JP2006512924A5 (enExample) | ||
| JP2004538280A5 (enExample) | ||
| JPH1180090A5 (enExample) | ||
| JP2005509735A5 (enExample) | ||
| EP1153924A3 (en) | Substituted 1,3-oxathiolanes with antiviral properties | |
| JP2005516908A5 (enExample) | ||
| RU98123954A (ru) | Алкилзамещенные циклические амины в качестве селективных лигандов d3-допамина | |
| EA200400140A1 (ru) | Пероральные противодиабетические агенты | |
| JPWO2023060253A5 (enExample) | ||
| JP2004531479A5 (enExample) | ||
| JP2003506378A5 (enExample) | ||
| JPH1087577A5 (enExample) | ||
| JP2004516329A5 (enExample) | ||
| JP2006518765A5 (enExample) | ||
| JP2005504738A5 (enExample) | ||
| JP2001518468A5 (enExample) | ||
| JP2004149774A5 (enExample) | ||
| RU93005087A (ru) | 3-(тиазолидинилбутил-4-пиперазинил)-ih-индазолы | |
| JP2002220391A5 (enExample) |